Ectopic adrenocorticotropic hormone syndrome caused by metastatic carcinoma of the prostate: Therapeutic response to ketoconazole

Endocrine Practice

Volumn 8, Issue 5, 2002, Pages 381-384

  Hussein, Wiam I ^a   Kowalyk, Stephan ^a   Hoogwerf, Byron J ^a  

^a SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; INSULIN; KETOCONAZOLE; NIFEDIPINE; POTASSIUM;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CUSHING SYNDROME; DRUG RESPONSE; ECTOPIC CORTICOTROPIN PRODUCTION; EDEMA; HUMAN; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIC ALKALOSIS; MALE; METASTASIS; ORCHIECTOMY; PATHOLOGIC FRACTURE; PROSTATE ADENOCARCINOMA; SYMPTOMATOLOGY; TOTAL HIP PROSTHESIS;

EID: 0036737855     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.8.5.381     Document Type: Article

References (28)

1. Farwell AP, Devlin JT, Stewart JA. Total suppression of cortisol excretion by ketoconazole in the therapy of the ectopic adrenocorticotropic hormone syndrome. Am J Med. 1988;84:1063-1066.
2. Tabarin A, Navarranne A, Guerin J, Corcuff JB, Parneix M, Roger P. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome. Clin Endocrinol (Oxf). 1991;34:63-69.
3. Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA. Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production. J Clin Oncol. 1995;13: 157-164.
4. Carey RM, Varma SK, Drake CR Jr, et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome: a clinical, morphologic, and biochemical study. N Engl J Med. 1984;311:13-20.
5. Belsky JL, Cuello B, Swanson LW, Simmons DM, Jarrett RM, Braza F. Cushing's syndrome due to ectopic production of corticotropin-releasing factor. J Clin Endocrinol Metab. 1985;60:496-500.
6. Schteingart DE, Lloyd RV, Akil H, et al. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab. 1986;63:770-775.
7. Yesner R. Spectrum of lung cancer and ectopic hormones. Pathol Annu. 1978;13(Pt 1):207-240.
8. Lovern WJ, Fariss BL, Wettlaufer JN, Hane S. Ectopic ACTH production in disseminated prostatic adenocarcinoma. Urology. 1975;5:817-820.
9. Newmark SR, Dluhy RG, Bennett AH. Ectopic adrenocorticotropin syndrome with prostatic carcinoma. Urology. 1973;2:666-668.
10. Vuitch MF, Mendelsohn G. Relationship of ectopic ACTH production to tumor differentiation: a morphologic and immunohistochemical study of prostatic carcinoma with Cushing's syndrome. Cancer. 1981;47:296-299.
11. Wenk RE, Bhagavan BS, Levy R, Miller D, Weisburger W. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer. 1977;40:773-778.
12. Ghali VS, Garcia RL. Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome: immunohistochemical study and review of the literature. Cancer. 1984;54:1043-1048.
13. Molland EA. Prostatic adenocarcinoma with ectopic ACTH production. Br J Urol. 1978;50:358.
14. Fjellestad-Paulsen A, Abrahamsson PA, Bjartell A, et al. Carcinoma of the prostate with Cushing's syndrome: a case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. Acta Endocrinol (Copenh). 1988;119:506-516.
15. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 1987;317:812-818.
16. Pont A, Williams PL, Loose DS, et al. Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med. 1982; 97:370-372.
17. Pont A, Williams PL, Azhar S, et al. Ketoconazole blocks testosterone synthesis. Arch Intern Med. 1982;142: 2137-2140.
18. DeFelice R, Johnson DG, Galgiani JN. Gynecomastia with ketoconazole. Antimicrob Agents Chemother. 1981; 19:1073-1074.
19. Kraemer FB, Pont A. Inhibition of cholesterol synthesis by ketoconazole. Am J Med. 1986;80:616-622.
20. Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983; 71:1495-1499.
21. Denis L, Chaban M, Mahler C. Clinical applications of ketoconazole in prostate cancer. In: EORTC Genitourinary Group Monograph 2, Part A: Therapeutic Principles in Metastatic Prostatic Cancer. New York: Alan R. Liss, Inc., 1985: 319-326.
22. Trachtenberg J, Halpern N, Pont A. Ketoconazole: a novel and rapid treatment for advanced prostatic cancer. J Urol. 1983;130:152-153.
23. Trachtenberg J, Pont A. Ketoconazole therapy for advanced prostate cancer. Lancet. 1984;2:433-435.
24. Loli P, Berselli,ME, Tagliaferri M. Use of ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab. 1986;63:1365-1371.
25. Angeli A, Frairia R. Ketoconazole therapy in Cushing's disease [letter]. Lancet. 1985;1:821.
26. Sonino N, Boscaro M, Merola G, Mantero F. Prolonged treatment of Cushing's disease by ketoconazole. J Clin Endocrinol Metab. 1985;61:718-722.
27. Contreras P, Altieri E, Liberman C, et al. Adrenal rest tumor of the liver causing Cushing's syndrome: treatment with ketoconazole preceding an apparent surgical cure. J Clin Endocrinol Metab. 1985;60:21-28.
28. Shepherd FA, Hoffert B, Evans WK, Emery G, Trachtenberg J. Ketoconazole: use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancer. Arch Intern Med. 1985;145:863-864.